|
Pharmaceutical Pricing, Reimbursement, and Regulatory Affairs News in the Fourth Quarter of 2004Published by: Decision Resources Published: Mar. 21, 2005 - 14 Pages The price of this report has been reduced due to its age. The original price was $1,900 for PDF E-mail From Publisher.Table of Contents
AbstractWhat impact will the reelection of George W. Bush to the U.S. presidency have on the pharmaceutical industry? How is the role of generics expanding and influencing pharmaceutical industry dynamics? In this report, we review these and other developments in the fourth quarter of 2004 in the areas of pharmaceutical pricing, reimbursement, and regulatory affairs. We focus on measures that health care payers are using to curb their drug expenditures and improve patient access to medications. We conclude with an assessment of the outlook and implications for the pharmaceutical industry.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||